Inotuzumab ozogamicin - Pfizer
At a glance
- Drug Originator Celltech Group; Wyeth
- Drug Class Antineoplastics; Cytostatic antibiotics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action DNA damage stimulants
- USA Patent Applicants WYETH PHARMS INC
- USA Patents 25
- BLAs 1
- International Patents 405
Disclaimer